(Q36764001)

16 August 2017

1 reference

title

Investigational treatments of venous thromboembolism (English)

1 reference

16 August 2017

Alex C Spyropoulos

1

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 April 2007

1 reference

Expert Opinion on Investigational Drugs

16 August 2017

published in

1 reference

16 August 2017

volume

16

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

431-440

1 reference

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.431

Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.431

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.431

Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.431

New anticoagulant drugs: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.431

Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.431

Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.431

Secondary prophylaxis with warfarin for venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.431

Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.431

A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.431

The pathophysiology of heparin-induced thrombocytopenia: biological basis for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.431

Effect of different types of thrombin inhibitors on thrombin/thrombomodulin modulated activation of protein C in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.431

Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.431

Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.431

Secondary Prevention of Venous Thromboembolism with the Oral Direct Thrombin Inhibitor Ximelagatran

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.431

Ximelagatran vs low-molecular-weight heparin and warfarin for the treatment of deep vein thrombosis: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.431

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.16.4.431

10.1517/13543784.16.4.431

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference